Most and least shorted mid-to mega-cap healthcare stocks in March
Seeking Alpha News (Fri, 3-Apr 8:00 AM ET)
Danaher Sets April 21 for Q1 2026 Earnings Call—What to Watch as Investors Await New Guidance
Market Chameleon (Mon, 23-Mar 5:32 AM ET)
Danaher Schedules First Quarter 2026 Earnings Conference Call
PRNewswire (Fri, 20-Mar 4:15 PM ET)
Did Danaher Corporation Insiders Breach their Fiduciary Duties to Shareholders?
PRNewswire (Thu, 12-Mar 3:47 PM ET)
Danaher Announces Quarterly Dividend
PRNewswire (Tue, 24-Feb 4:30 PM ET)
Danaher to Present at TD Cowen Health Care Conference
PRNewswire (Tue, 24-Feb 4:05 PM ET)
Business Wire (Wed, 18-Feb 8:30 PM ET)
Danaher to Acquire Masimo for $9.9 Billion: What This Means for the Diagnostics Sector
Market Chameleon (Tue, 17-Feb 3:18 AM ET)
Masimo to be Acquired by Danaher for $180.00 Per Share
Business Wire (Tue, 17-Feb 8:02 AM ET)
Danaher To Acquire Masimo Corporation
PRNewswire (Tue, 17-Feb 8:00 AM ET)
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life sciences and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.
Danaher trades on the NYSE stock market under the symbol DHR.
As of April 6, 2026, DHR stock price climbed to $192.12 with 2,407,660 million shares trading.
DHR has a beta of 1.16, meaning it tends to be more sensitive to market movements. DHR has a correlation of 0.40 to the broad based SPY ETF.
DHR has a market cap of $135.86 billion. This is considered a Large Cap stock.
Last quarter Danaher reported $7 billion in Revenue and $2.23 earnings per share. This beat revenue expectation by $36 million and exceeded earnings estimates by $.06.
In the last 3 years, DHR traded as high as $281.70 and as low as $171.00.
The top ETF exchange traded funds that DHR belongs to (by Net Assets): VTI, VOO, IVV, SPY, VTV.
DHR has underperformed the market in the last year with a return of -5.7%, while the SPY ETF gained +18.0%. In the last 3 month period, DHR fell short of the market, returning -16.4%, while SPY returned -3.3%. However, in the most recent 2 weeks DHR has outperformed the stock market by returning +1.3%, while SPY returned +0.4%.
DHR support price is $187.41 and resistance is $194.83 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DHR shares will trade within this expected range on the day.